OLIVA, STEFANIA
OLIVA, STEFANIA
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
2021-01-01 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma
2016-01-01 Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
2020-01-01 Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P.
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis
2017-01-01 Gay F, Oliva S, Petrucci MT, Montefusco V, Conticello C, Musto P, Catalano L, Evangelista A, Spada S, Campbell P, Ria R, Salvini M, Offidani M, Carella AM, Omedé P, Liberati AM, Troia R, Cafro AM, Malfitano A, Falcone AP, Caravita T, Patriarca F, Nagler A, Spencer A, Hajek R, Palumbo A, Boccadoro M.
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results
2013-01-01 Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A.
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?
2021-01-01 Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M.
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study.
2014-01-01 Bringhen S;Petrucci MT;Larocca A;Conticello C;Rossi D;Magarotto V;Musto P;Boccadifuoco L;Offidani M;Omedé P;Gentilini F;Ciccone G;Benevolo G;Genuardi M;Montefusco V;Oliva S;Caravita T;Tacchetti P;Boccadoro M;Sonneveld P;Palumbo A
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino
2019-01-01 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial
2015-01-01 Gay, Francesca; Oliva, Stefania; Petrucci, Maria Teresa; Conticello, Concetta; Catalano, Lucio; Corradini, Paolo; Siniscalchi, Agostina; Magarotto, Valeria; Pour, Luděk; Carella, Angelo; Malfitano, Alessandra; Petrò, Daniela; Evangelista, Andrea; Spada, Stefano; Pescosta, Norbert; Omedè, Paola; Campbell, Philip; Liberati, Anna Marina; Offidani, Massimo; Ria, Roberto; Pulini, Stefano; Patriarca, Francesca; Hajek, Roman; Spencer, Andrew; Boccadoro, Mario; Palumbo, Antonio
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
2020-01-01 Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A.
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
2020-01-01 Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A.
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set
2020-01-01 Chari A.; Samur M.K.; Martinez-Lopez J.; Cook G.; Biran N.; Yong K.; Hungria V.; Engelhardt M.; Gay F.; Feria A.G.; Oliva S.; Oostvogels R.; Gozzetti A.; Rosenbaum C.; Kumar S.; Stadtmauer E.A.; Einsele H.; Beksac M.; Weisel K.; Anderson K.C.; Mateos M.-V.; Moreau P.; San-Miguel J.; Munshi N.C.; Avet-Loiseau H.
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
2021-01-01 Sonneveld, Pieter; Dimopoulos, Meletios A; Beksac, Meral; van der Holt, Bronno; Aquino, Sara; Ludwig, Heinz; Zweegman, Sonja; Zander, Thilo; Zamagni, Elena; Wester, Ruth; Hajek, Roman; Pantani, Lucia; Dozza, Luca; Gay, Francesca; Cafro, AnneMaria; De Rosa, Luca; Morelli, Annamaria; Gregersen, Henrik; Gulbrandsen, Nina; Cornelisse, Petra; Troia, Rosella; Oliva, Stefania; van de Velden, Vincent; Wu, KaLung; Ypma, Paula F; Bos, Gerard; Levin, Mark-David; Pour, Luca; Driessen, Christoph; Broijl, Annemiek; Croockewit, Alexandra; Minnema, Monique C; Waage, Anders; Hveding, Cecilie; van de Donk, Niels W C J; Offidani, Massimo; Palumbo, Giuseppe A; Spencer, Andrew; Boccadoro, Mario; Cavo, Michele
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
2020-01-01 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
Evaluation of immunophenotyc and molecular profiles for Minimal residual disease assessment in multiple myelom: correlation with clinical features and outcome
2021-11-25
From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives
2018-01-01 Gay, Francesca; Engelhardt, Monika; Terpos, Evangelos; Wäsch, Ralph; Giaccone, Luisa; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Van De Donk, Niels; Oliva, Stefania; Zamagni, Elena; Garderet, Laurent; Straka, Christian; Hajek, Roman; Ludwig, Heinz; Einsele, Herman; Dimopoulos, Meletios; Boccadoro, Mario; Kröger, Nicolaus; Cavo, Michele; Goldschmidt, Hartmut; Bruno, Benedetto*; Sonneveld, Pieter
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma
2021-01-01 Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
2024-01-01 Ziccheddu, Bachisio; Giannotta, Claudia; D'Agostino, Mattia; Bertuglia, Giuseppe; Saraci, Elona; Oliva, Stefania; Genuardi, Elisa; Papadimitriou, Marios; Diamond, Benjamin; Corradini, Paolo; Coffey, David; Landgren, Ola; Bolli, Niccolò; Bruno, Benedetto; Boccadoro, Mario; Massaia, Massimo; Maura, Francesco; Larocca, Alessandra
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
2022-01-01 Bertamini, Luca; Oliva, Stefania; Rota-Scalabrini, Delia; Paris, Laura; Morè, Sonia; Corradini, Paolo; Ledda, Antonio; Gentile, Massimo; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Curci, Paola; Gilestro, Milena; Capra, Andrea; Galieni, Piero; Pisani, Francesco; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Luppi, Mario; Zambello, Renato; Fazio, Francesca; Belotti, Angelo; Tacchetti, Paola; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate
2020-01-01 Milani P.; Fazio F.; Basset M.; Berno T.; Larocca A.; Foli A.; Riva M.; Benigna F.; Oliva S.; Nuvolone M.; Rodigari L.; Petrucci M.T.; Merlini G.; Palladini G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma | 2021 | Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P. | |
| A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma | 2016 | Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A | |
| Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study | 2020 | Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P. | |
| Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis | 2017 | Gay F, Oliva S, Petrucci MT, Montefusco V, Conticello C, Musto P, Catalano L, Evangelista A, Spada S, Campbell P, Ria R, Salvini M, Offidani M, Carella AM, Omedé P, Liberati AM, Troia R, Cafro AM, Malfitano A, Falcone AP, Caravita T, Patriarca F, Nagler A, Spencer A, Hajek R, Palumbo A, Boccadoro M. | |
| Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results | 2013 | Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A. | |
| Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved? | 2021 | Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M. | |
| Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. | 2014 | Bringhen S;Petrucci MT;Larocca A;Conticello C;Rossi D;Magarotto V;Musto P;Boccadifuoco L;Offidani M;Omedé P;Gentilini F;Ciccone G;Benevolo G;Genuardi M;Montefusco V;Oliva S;Caravita T;Tacchetti P;Boccadoro M;Sonneveld P;Palumbo A | |
| Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro | |
| Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial | 2015 | Gay, Francesca; Oliva, Stefania; Petrucci, Maria Teresa; Conticello, Concetta; Catalano, Lucio; Corradini, Paolo; Siniscalchi, Agostina; Magarotto, Valeria; Pour, Luděk; Carella, Angelo; Malfitano, Alessandra; Petrò, Daniela; Evangelista, Andrea; Spada, Stefano; Pescosta, Norbert; Omedè, Paola; Campbell, Philip; Liberati, Anna Marina; Offidani, Massimo; Ria, Roberto; Pulini, Stefano; Patriarca, Francesca; Hajek, Roman; Spencer, Andrew; Boccadoro, Mario; Palumbo, Antonio | |
| Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma | 2020 | Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A. | |
| Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents | 2020 | Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A. | |
| Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set | 2020 | Chari A.; Samur M.K.; Martinez-Lopez J.; Cook G.; Biran N.; Yong K.; Hungria V.; Engelhardt M.; Gay F.; Feria A.G.; Oliva S.; Oostvogels R.; Gozzetti A.; Rosenbaum C.; Kumar S.; Stadtmauer E.A.; Einsele H.; Beksac M.; Weisel K.; Anderson K.C.; Mateos M.-V.; Moreau P.; San-Miguel J.; Munshi N.C.; Avet-Loiseau H. | |
| Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma | 2021 | Sonneveld, Pieter; Dimopoulos, Meletios A; Beksac, Meral; van der Holt, Bronno; Aquino, Sara; Ludwig, Heinz; Zweegman, Sonja; Zander, Thilo; Zamagni, Elena; Wester, Ruth; Hajek, Roman; Pantani, Lucia; Dozza, Luca; Gay, Francesca; Cafro, AnneMaria; De Rosa, Luca; Morelli, Annamaria; Gregersen, Henrik; Gulbrandsen, Nina; Cornelisse, Petra; Troia, Rosella; Oliva, Stefania; van de Velden, Vincent; Wu, KaLung; Ypma, Paula F; Bos, Gerard; Levin, Mark-David; Pour, Luca; Driessen, Christoph; Broijl, Annemiek; Croockewit, Alexandra; Minnema, Monique C; Waage, Anders; Hveding, Cecilie; van de Donk, Niels W C J; Offidani, Massimo; Palumbo, Giuseppe A; Spencer, Andrew; Boccadoro, Mario; Cavo, Michele | |
| Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing | 2020 | D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca | |
| Evaluation of immunophenotyc and molecular profiles for Minimal residual disease assessment in multiple myelom: correlation with clinical features and outcome | 2021 | - | |
| From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives | 2018 | Gay, Francesca; Engelhardt, Monika; Terpos, Evangelos; Wäsch, Ralph; Giaccone, Luisa; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Van De Donk, Niels; Oliva, Stefania; Zamagni, Elena; Garderet, Laurent; Straka, Christian; Hajek, Roman; Ludwig, Heinz; Einsele, Herman; Dimopoulos, Meletios; Boccadoro, Mario; Kröger, Nicolaus; Cavo, Michele; Goldschmidt, Hartmut; Bruno, Benedetto*; Sonneveld, Pieter | |
| Functional impact of genomic complexity on the transcriptome of Multiple Myeloma | 2021 | Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò | |
| Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma | 2024 | Ziccheddu, Bachisio; Giannotta, Claudia; D'Agostino, Mattia; Bertuglia, Giuseppe; Saraci, Elona; Oliva, Stefania; Genuardi, Elisa; Papadimitriou, Marios; Diamond, Benjamin; Corradini, Paolo; Coffey, David; Landgren, Ola; Bolli, Niccolò; Bruno, Benedetto; Boccadoro, Mario; Massaia, Massimo; Maura, Francesco; Larocca, Alessandra | |
| High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma | 2022 | Bertamini, Luca; Oliva, Stefania; Rota-Scalabrini, Delia; Paris, Laura; Morè, Sonia; Corradini, Paolo; Ledda, Antonio; Gentile, Massimo; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Curci, Paola; Gilestro, Milena; Capra, Andrea; Galieni, Piero; Pisani, Francesco; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Luppi, Mario; Zambello, Renato; Fazio, Francesca; Belotti, Angelo; Tacchetti, Paola; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca | |
| High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate | 2020 | Milani P.; Fazio F.; Basset M.; Berno T.; Larocca A.; Foli A.; Riva M.; Benigna F.; Oliva S.; Nuvolone M.; Rodigari L.; Petrucci M.T.; Merlini G.; Palladini G. |